Potentiation by estramustine of the cytotoxic effect of vinblastine and doxorubicin in prostatic tumor cells
Open Access
- 27 November 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 68 (5), 644-649
- https://doi.org/10.1002/(sici)1097-0215(19961127)68:5<644::aid-ijc15>3.0.co;2-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Binding of vinblastine and estramustine to isolated plasma membrane fractions from human prostate and prostatic tumorsCancer Letters, 1996
- P-glycoprotein Binding and Modulation of the Multidrug-Resistant Phenotype by EstramustineJNCI Journal of the National Cancer Institute, 1994
- Ketoconazole Effectively Reverses Multidrug Resistance in Highly Resistant KB CellsJournal of Urology, 1994
- Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.Journal of Clinical Oncology, 1992
- Estramustine and Vinblastine: Use of Prostate Specific Antigen as a Clinical Trial End Point for Hormone Refractory Prostatic CancerJournal of Urology, 1992
- Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.The Journal of cell biology, 1988
- ErratumAnalytical Biochemistry, 1987
- Measurement of protein using bicinchoninic acidAnalytical Biochemistry, 1985
- The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancerMedical and Pediatric Oncology, 1982
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970